- We provide supply of cGMP cytisine API in bulk, produced in FDA inspected installations in the USA, for use as smoking cessation agent.
- We develop a small molecule (natural product) for treatment of opioids use disorder and for pain management.
We, at Coryn Pharmaceuticals LLC (US), we require an investment for manufacturing first batch of 1-10kg of cGMP cytisine API. The investment will be recovered from the sales of the manufactured cytisine API.
Current development status
Finished technologies
Use of Proceeds
- Buying raw material Cytisine extract.
Use of Proceeds
Payment of the manufacturing development costs of the cytisine API in bulk.
Elaboration of platform technologies for sustainable production of active pharmaceutical ingredients (API) from biomass and using sustainable ressources, respectful to the environment and clima change.
Development of natural products as drugs against addiction and pain management.
Create your free account to connect with Dr. Thomas Kallimopoulos and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Dr.
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
